Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer

This study has been completed.

Sponsor:

Information provided by:

Agenus, Inc.

ClinicalTrials.gov Identifier:

NCT00098085

First received: December 3, 2004

Last updated: March 6, 2009

Last verified: March 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	November 2007 (Final data collection date for primary outcome measure)